A new study describes the complexity of the new T cell repertoire following immune-depleting therapy to treat multiple sclerosis, improving our understanding of immune tolerance and clinical outcomes. In the Immune Tolerance Network's ...
Tags: Immune System Reconstitutes Itself, Immune-Depleting Therapy
The sea sponge is about as simple as an animal can get, but its associated bacterial community—its microbiome —is known to approach the complexity of the diverse microbiome in the human gut. Now, scientists at the Marine ...
Tags: Consumer Electronics, Electronics
Illumina, Inc. (NASDAQ:ILMN) today announced it has entered into a multi-year licensing agreement with Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, related to the use of Illumina's ...
Tags: Illumina, multi-year licensing agreement, Quest Diagnostics
Next-generation genetic sequencing, the idea of cheap and accessible testing, is one of the trendy areas in the medical device industry and a potential game-changer in the testing equipment sector. Just this week, GenapSys of Redwood ...
US-based Illumina has announced the introduction of its TruGenome undiagnosed disease test provided by Illumina Clinical Services Laboratory (ICSL). Using whole human genome sequencing, the TruGenome test helps clinicians in identifying ...
Tags: Illumina, Undiagnosed Disease Test
Bioplastics are emerging as viable alternatives to petroleum-based polymers. This quiet revolution goes well beyond the standard drivers for sustainably sourced and/or compostable materials. I attended the 2013 BioPlastek conference in San ...
Tags: Bioplastic Revolution
Genia Technologies in consortium with Columbia University and Harvard Medical School, has secured a three-year $5.25m grant from the National Human Genome Research Institute (NHGRI) of the National Institutes of Health (NIH), to develop ...
Tags: Health, Medicine, DNA Sequencing Platform
Pathogenica and Illumina have entered into an agreement to co-market a new version of the former’s HAI BioDetection kit in the Asia Pacific region. Currently under development and compatible with Illumina's MiSeq benchtop sequencing ...
Tags: Biodetection Kit, Medicine
Life Technologies along with Aridhia, a biomedical informatics company, will provide the genetic analysis platform with its semiconductor based, Ion Proton DNA sequencing technology to the Stratified Medicine Scotland Innovation Centre ...
Tags: Life Technologies
US-based clinicians software provider Cartagenia has signed a licensing agreement with non-profit institute Greenwood Genetic Center for its BENCHlab NGS and CNV solutions. Cartagenia's BENCHlab CNV solution helps labs to deploy ...
China-based BGI-Shenzhen, through its subsidiary Beta Acquisition, has purchased Complete Genomics, a provider of whole human genome sequencing services. US-based Complete's products include advanced informatics and analysis systems that ...
Agilent Technologies Inc and SRI International have announced they have signed a licensing agreement to offer laboratory research customers a package that combines Agilent’s latest release of GeneSpring GX, GeneSpring NGS, Mass ...
Harvard researchers have been able to use sequencing technology to store 70 billion copies of a yet-unpublished book in DNA binary code. The results of the project by researchers at Harvard University's Wyss Institute for Biologically ...
Tags: Harvard, sequencing technology, DNA binary code, 70 billion books
LED-based sequencer to track Salmonella and E.coli 18 Sep 2012 US Food&Drug Administration agrees$17??million contract for sequencing systems to track future outbreaks of potentially harmful pathogens. Illumina,the San Diego company ...
Tags: the San Diego company, LED, Salmonella, E.Coli, MiSeq systems
Genewiz, a provider of DNA services, has obtained clinical laboratory improvement amendments (CLIA) certification. The certification allows the company to expand its clinical genomic testing solutions, thus contributing to advancements in ...
Tags: DNA services, CLIA Certification, clinical genomic testing